Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Myasthenia Gravis”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Early research (Phase 1)Active Not RecruitingNCT06958939
What this trial is testing

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ting Chang, MD 10
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Large-scale testing (Phase 3)Study completedNCT03759366
What this trial is testing

Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Juvenile FormMyasthenia Gravis, Generalized
Alexion Pharmaceuticals, Inc. 12
Very early researchNot Yet RecruitingNCT07243366
What this trial is testing

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

Who this might be right for
Refractory Myasthenia Gravis
Guangdong ProCapZoom Biosciences Co., Ltd. 15
Not applicableNot Yet RecruitingNCT07499323
What this trial is testing

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
First Affiliated Hospital of Chongqing Medical University 2
Large-scale testing (Phase 3)Not Yet RecruitingNCT06836973
What this trial is testing

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Da, Yuwei, M.D. 2
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Not applicableActive Not RecruitingNCT06700616
What this trial is testing

A Study in Patients With Myasthenia Gravis in China

Who this might be right for
Myasthenia Gravis
AstraZeneca 1,199
Not applicableUnknownNCT00997412
What this trial is testing

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Qualitix Clinical Research Co., Ltd. 40
Very early researchWithdrawnNCT06419166
What this trial is testing

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Who this might be right for
Refractory Generalized Myasthenia Gravis
Zhejiang University
Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Not applicableLooking for participantsNCT07413835
What this trial is testing

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

Who this might be right for
Refractory Myasthenia Gravis
The Affiliated Hospital of Xuzhou Medical University 6
Early research (Phase 1)Ended earlyNCT00424489
What this trial is testing

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Northwestern University 9
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Early research (Phase 1)Looking for participantsNCT06688435
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 60
Next Page